Skip to main content
OPKO Health Inc. logo

OPKO Health Inc. — Investor Relations & Filings

Ticker · OPK ISIN · US68375N1037 LEI · 529900A4S2D4OGOJLL02 TA Human health and social work activities
Open in API
Filings indexed 3,780 across all filing types
Latest filing 2026-04-28 Report Publication Anno…
Country US United States of America
Listing TA OPK

About OPKO Health Inc.

https://www.opko.com

OPKO Health, Inc. is a fully-integrated healthcare company operating in both pharmaceuticals and diagnostics. Its pharmaceutical division develops and commercializes novel therapies for serious diseases. Key marketed products include NGENLA™, a long-acting treatment for pediatric growth hormone deficiency partnered with Pfizer, and RAYALDEE®. The company's research focuses on advancing multispecific therapies for cancers and infectious diseases. Through its subsidiary, BioReference Laboratories, OPKO operates one of the largest full-service clinical reference laboratories in the U.S., providing comprehensive diagnostic testing services to millions of patients annually.

Recent filings

Filing Released Lang Actions
Immediate Report
Report Publication Announcement Classification · 85% confidence The document is an “Immediate Report” filed with the Israel Securities Authority. It does not contain the actual financial results or the text of the Form 8-K; rather it announces that the Form 8-K “OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results” is attached. This fits the definition of a Report Publication Announcement (RPA) since it simply notifies regulators and the market that the report has been published and is available as an attachment.
2026-04-28 English
Report of Periodic or Interim Report
Interim / Quarterly Report Classification · 95% confidence The document is titled “Form 10-Q” and clearly identifies itself as a “Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934” for the quarterly period ended March 31, 2026. It contains unaudited condensed consolidated financial statements, Management’s Discussion and Analysis, market risk disclosures, controls and procedures, and other typical 10-Q items. This matches the definition for an Interim/Quarterly Report (IR). Q1 2026
2026-04-28 English
Report of Periodic or Interim Report
Report Publication Announcement Classification · 85% confidence The document is a short (1,865-character) Israeli regulatory submission that merely states “Attached hereto is a report on Form 10-Q for quarter 1, 2026” with a filename, rather than containing the full quarterly financial statements itself. Under the “menu vs. meal” rule for announcements under 5,000 characters that link or attach a fuller report, this is classified as a Report Publication Announcement (RPA), not the report itself.
2026-04-28 English
Immediate Report
Regulatory Filings Classification · 95% confidence The document is a corporate press release announcing the start of a clinical trial for a novel oncology drug. It does not report financial results or regulatory form submissions, nor does it constitute an investor presentation or formal report. It is a general corporate announcement or ‘regulatory news’ type release that does not fit specialized categories. Therefore the fallback filing type is Regulatory Filings (RNS).
2026-04-22 English
Immediate Report
Report Publication Announcement Classification · 90% confidence The document is an Immediate Report under Israeli Securities Regulations comprising a short announcement that a detailed report (PDF) is attached. It provides metadata, references to the attachment, and does not include substantive content of the clinical trial itself. Hence, per the “menu vs meal” rule this is a Report Publication Announcement (RPA).
2026-04-22 English
Immediate Report
Report Publication Announcement Classification · 95% confidence The document is a press release announcing when OPKO Health will report its Q1 2026 financial results and host a conference call; it contains no actual financial results. According to the “menu vs meal” rule and the definition of RPA, this is an announcement regarding the timing of an upcoming report rather than the report itself.
2026-04-22 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.